Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. BIOA
BIOA logo

BIOA

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

BIOA News

BioAge Labs Reports Q1 2026 Financial Results with Key Metrics

2d agoseekingalpha

BioAge Labs Reports Positive Phase 1 Data for BGE-102

2d agoNewsfilter

Leqembi Iqlik PDUFA Date Extended to August 24

3d agoNewsfilter

BioAge Labs Announces R&D Day Webcast Featuring BGE-102 Data

6d agoNewsfilter

BioAge Labs' BGE-102 Shows Promising Phase 1 Results

Apr 21 2026NASDAQ.COM

BioArctic Publishes 2025 Annual and Sustainability Reports

Apr 21 2026Newsfilter

BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference

Apr 13 2026Newsfilter

BIOAGE LABS INC: NEEDHAM BEGINS COVERAGE WITH A BUY RATING AND A TARGET PRICE OF $50

Mar 27 2026moomoo

BioArctic Nomination Committee Proposes Board Members

Mar 27 2026Newsfilter

BioAge Labs Reports FY EPS Beat and Strong Cash Position

Mar 24 2026seekingalpha

BIOAGE LABS ANNOUNCES 2025 FULL YEAR FINANCIAL RESULTS AND FOURTH QUARTER BUSINESS UPDATES

Mar 24 2026moomoo

BioArctic Presents New Data on Lecanemab at Alzheimer's Conference

Mar 23 2026Newsfilter

BioArctic Presents New Data at Alzheimer's Conference

Mar 23 2026PRnewswire

BioArctic AB Issues 78,000 Class B Shares Under Stock Option Program

Feb 27 2026Newsfilter

Wall Street Analysts Adjust Ratings

Feb 25 2026Benzinga

BioAge Labs to Present at Oppenheimer Healthcare Conference

Feb 19 2026Newsfilter